The Hindu Business Line : Biocon gets global ranking of 20

Bangalore, July 17 Biocon Ltd has been ranked at number 20 amongst the top 25 global biotechnology companies by revenue, according to a report released by Med Ad News. Biocon is the only Asian company in the report that has been considered among drug-based firms for the ranking.

A company release quoted Ms Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon Ltd, as saying, “It is a matter of immense pride for Biocon to be ranked amongst the top global league of biotech companies. This is a validation of our consistent effort at attaining global leadership and also highlights the true potential of this sector in India. This industry will be a key driver in India’s progress towards economic development.”

19 in US

The top 25 represent 62 per cent of all biotech sales and probably over 90 per cent of income. Nineteen of them are based in the US, the remaining six are from Europe, India and Australia. There are nearly 5,000 biotech companies across the globe.

BIO 2008, held in San Diego in June, estimated that the global biotechnology industry will be a $100-billion (Rs 4,00,000 crore) annual business by 2010 — up from $85 billion (Rs 3,30,000 crore) in 2007.

More Stories on : Performance | Pharmaceuticals | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Hindustan Copper’s Ghatsila rail network on a modernisation track

Glenmark molecule phase I trials

ICI defers second share buy-back plan

Kirby bags Rs 190-cr Renault-Nissan contract

HC stays auctioning of Bajaj unit’s properties

Generic drug makers’ concern over Ranbaxy-USFDA stand-off

Maytas Properties launches IT SEZ near Hyderabad

ICI plans greenfield plant

Iffco to invest $800 m for rock phosphate mining in Australia

Vakil Housing eyes Coimbatore realty market

Biocon gets global ranking of 20